SUVEN PHARMACEUTICALS
Back to Income Statement
|
SUVEN PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹300 Cr | ₹41,129 Cr | ₹454 Cr | ₹362 Cr | ₹317 Cr |
What is the latest Consolidated Net Profit of SUVEN PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹300 Cr |
| Mar2024 | ₹41,129 Cr |
| Mar2023 | ₹454 Cr |
| Mar2022 | ₹362 Cr |
| Mar2021 | ₹317 Cr |
How is Consolidated Net Profit of SUVEN PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹300 Cr | -99.27 | |
| Mar2024 | ₹41,129 Cr | 8,963.15 | |
| Mar2023 | ₹454 Cr | 25.24 | |
| Mar2022 | ₹362 Cr | 14.30 | |
| Mar2021 | ₹317 Cr | - | |
Compare Consolidated Net Profit of peers of SUVEN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN PHARMACEUTICALS | ₹11,390.0 Cr | -3.7% | -19.8% | -74.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,728.0 Cr | -0.8% | 7.4% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,236.0 Cr | -1.5% | 5.7% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,951.0 Cr | -1.8% | 8.8% | 44.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,765.0 Cr | -1.2% | 9.2% | 14.9% | Stock Analytics | |
| CIPLA | ₹106,033.0 Cr | -2.5% | 0.1% | -7.6% | Stock Analytics | |
SUVEN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN PHARMACEUTICALS | -3.7% |
-19.8% |
-74.9% |
| SENSEX | -3.8% |
-2% |
6.3% |
You may also like the below Video Courses